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Background: Physical exercise and a Mediterranean diet improve serum lipid profile. The present work studied
whether red wine has an effect on top of a lipid-lowering lifestyle in patients with carotid atherosclerosis.
Methods: A prospective randomised unblinded trial was performed from 2009 to 2011 in 108 patients with carotid
atherosclerosis, 65% of whom were already on statin therapy with a low mean LDL of 104.9 mg/dl. Half of them
were advised to follow a modified Mediterranean diet and to perform moderate physical exercise during 30 min/
day (lifestyle changes) for 20 weeks. Within these two groups half of the patients were randomised either to avoid
any alcohol or to drink 100 ml of red wine (women) or 200 ml of red wine (men) daily.
Results: LDL was significantly lowered by 7% in the lifestyle-changes group compared to the no-lifestyle-changes
group (p = 0.0296) after 20 weeks. Lifestyle changes lowered the LDL/HDL ratio after 20 weeks by 8% (p = 0.0242)
and red wine independently by 13% (p = 0.0049). The effect on LDL/HDL ratio after 20 weeks was, however, more
pronounced in the non-LC group. Total cholesterol (−6%; p = 0.0238) and triglycerides (−13%; p = 0.0361) were
lowered significantly by lifestyle changes after 20 weeks compared to the no-lifestyle-changes group. Lipoprotein
(a) was not significantly affected by any intervention. The given results are per ITT analysis.
Conclusions: Lifestyle changes including a modified Mediterranean diet and physical exercise as well as a glass of
red wine daily improve independently the LDL/HDL ratio in patients with carotid arteriosclerosis even though the
vast majority of them was already on statin therapy.
Trial registration: http://www.clinicaltrials.gov, NCT01146132
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There is a huge body of evidence from observational and
interventional studies that high serum total cholesterol,
LDL cholesterol and lipoprotein(a) (Lp(a)) levels, as well
as low HDL-cholesterol levels are related to cerebral and
cardiac vascular diseases [1-8]. The role of triglycerides
as an independent risk factor is less consistent as their
level clusters with other risk factors [2,9,10].* Correspondence: droste.dirk@chl.lu
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reproduction in any medium, provided the orLifestyle changes (LC) including physical exercise and
a Mediterranean diet improve lipid profile. Physical exer-
cise mainly increases HDL and reduces triglycerides;
LDL could be affected [11,12]. In an interventional trial
a Mediterranean diet enriched with mixed nuts or extra-
virgin olive oil decreased LDL cholesterol and triglycer-
ides, and increased HDL cholesterol [13]. In their recent
meta-analysis, Kastorini et al. found an increase in HDL
and a decrease in triglycerides when comparing a Medi-
terranean diet with conventional diet [14]. Some of the
studies in this meta-analysis included red wine, others
not. Three food items in particular have been shown toLtd. This is an open access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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nuts, the latter two being frequently part of a Mediterra-
nean diet [15-20]. Light to moderate alcohol consumption
(up to 1 drink daily for women and 1 or 2 drinks daily for
men) and possibly in particular red wine consumption is
associated with less cerebro- and cardiovascular diseases
and an improved lipid profile [21-26]. Regarding red wine
consumption (and other food items) the question is still open
whether lifestyle associated with moderate red wine con-
sumption or wine itself cause less cerebro-cardiovascular
disease [27]. Only in February 2013 the results of a large
prospective randomised trial were published showing a
benefit of mediterranean diet namely on stroke risk in
comparison to a low-fat diet (relative risk reduction of
33%-46%) [28].
In the present prospective unblinded randomised con-
trolled trial we assessed the effect of a small amount of
red wine and LC including the consumption of dark
chocolate, tomatoes and walnuts associated with phys-
ical activity advice on lipid profile in patients with
arteriosclerosis documented by carotid ultrasound. In
particular we studied whether the use of red wine on
top of LC still results in an additional lipid profile im-
provement. The present work is part of the ALVINA
project (an acronym of “alimentation, vin et activité
physique” which mean “nutrition, wine, and physical




122 patients were followed up to 20 weeks. The enrolled
participants were out-patients of the Neurology depart-
ment of the Centre Hospitalier de Luxembourg and had
undergone carotid and intracranial bitemporal color coded
duplex sonography using an Antares system (Siemens
Healthcare, 91052 Erlangen, Germany). Inclusion criteria
were >30 years and the presence of plaques or stenosis
without hemodynamic compromise (i.e. <70%) in at least
one common carotid artery, the carotid bifurcation, or the
internal carotid artery. We used the Mannheim definition
for plaques: It is defined as a focal structure that
encroaches into the arterial lumen of at least 0.5 mm or
50% of the surrounding IMT value or demonstrates a
thickness >1.5 mm as measured from the media-
adventitia interface to the intima-lumen interface [29].
NASCET criteria were used to define high-grade sten-
osis [30,31]. Exclusion criteria were a history of ocular
or cerebral ischemia within the last 3 months, atrial
fibrillation, or the incapacity to give informed consent.
This study was conducted according to the guidelines
laid down in the Declaration of Helsinki and all proce-
dures involving human subjects/patients were approved
by the national research ethics committee (200801/06)and notified to the national commission on data pro-
tection in Luxemburg. Written informed consent was
obtained from all subjects. The trial was registered
(http://www.clinicaltrials.gov, NCT01146132). The first
patient was included on June 4th 2009 and the last
follow-up visit was on October 10th 2011. The study
was performed in Luxemburg.
Intervention administered
The design of the study was a 2 × 2 factorial design. The
patients were attributed to groups of lifestyle in result of
a randomization stratified for gender. Lots were drawn
to generate the random allocation sequence. Block size
was four. The intervention allocation was concealed in a
non-transparent envelope. Random allocation sequence
was generated by an independent staff member; patients
were enrolled by the principal investigator; patients were
assigned to interventions by study nurse. The first group
received no lifestyle counseling and the second one re-
ceived lifestyle counseling at the beginning, after 1 week,
after 2 weeks, after 3 weeks and after 4 weeks. Within
each lifestyle group patients were either randomly ad-
vised to drink a glass of red wine a day (0.2 l for men
and 0.1 l for women), or advised to avoid alcohol at all
for the time of the study. The sort of red wine was at
the participants’ discretion.
Figure 1 gives an overview of the study procedures.
Only in the LC group, a dietician performed five sessions
of 30 min each (baseline, after one week, after 2 weeks,
after 3 weeks and after 4 weeks) giving advice on healthy
eating based on a modified Mediterranean diet and phys-
ical exercise. In particular, 5 portions of fruit/vegetables
per day, a diet low in absolute fat, a preference of
vegetable oil (olive or canola oil), whole grain products,
poultry, low fat dairy products, a fat and a lean fish meal
per week, a reduced consumption of red meat, and the
avoidance of pork, of ready-made meals, of sugar and of
excessive salt intake were recommended [32,33]. A water
intake of 1.5-2 l a day was recommended as well. In
addition the regular consumption of one bar of dark
chocolate (25 g, >70% of cacao), 1–2 tomatoes, and of
3–5 walnuts as well as at least 30 min of moderate daily
physical activity were recommended [32,34,35]. In the
literature the quantities of dark chocolate, tomatoes, and
walnuts are higher [17,20,36,37]; however we used quan-
tities applicable in daily life over a long period. The con-
trol group (no LC) was seen at baseline, after 4 weeks
and after 20 weeks by a nurse and instructed not to
change their eating and physical activity habits. The pa-
tients allocated to the wine group (within the LC and
the no-LC groups) underwent three short sessions of
counseling concerning the intake of red wine of their
choice (0.2 l for men and 0.1 l for women) by the nurse
[24,38,39].
1 week
Lifestyle changes group: Advice on diet and physical activity
2 weeks
Lifestyle changes group: Advice on diet and physical activity
3 weeks
Lifestyle changes group: Advice on diet and physical activity
4 weeks
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Physical activity questionnaire 
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Figure 1 Study procedures.
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All participants were initially seen by the dietician for a
baseline assessment of their nutrition habits over the last
2 working days and the last weekend day using the soft-
ware Nutrilog Pro (Nutrilog SAS, Marans, France). The
participants in the lifestyle-changes group were reassessed
at 4 weeks and at 20 weeks using the same method.
General anthropometrical data such as weight, height,
body-mass index were recorded. Physical activity over the
week preceding the clinical visit was assessed using a
questionnaire. Physical activity was differentiated into light
(no increase in respiration and sweating), moderate (increasein respiration, no sweating) and intense physical activity
(increased respiration and sweating) [32,34,35]. Daily
minutes of each exercise level were calculated. A scale
(model 763 1321009, Seca, Hamburg, Germany) was
used to assess body weight and a meter to assess height.
Fasting total cholesterol, LDL and HDL cholesterol, tri-
glycerides, and Lp(a) at baseline, after 4 weeks and
20 weeks were measured from serum samples collected
after a 12 hour fast. Total cholesterol, HDL-cholesterol,
LDL-cholesterol, triglycerides and Lp(a) were assessed on a
Modular P module (Roche, Basel, Switzerland). Total chol-
esterol, HDL-cholesterol, LDL-cholesterol and triglycerides
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(all Roche, Basel, Switzerland). An immunoturbidimetric
assay (Roche, Basel, Switzerland) was used tomeasure Lp(a).
Statistical analysis
The pre-defined primary endpoint of the study was a
change in the ratio LDL/HDL cholesterol assessed at
baseline and at 20 weeks. Secondary endpoints were
changes in the other above-mentioned blood parameters
and body weight/BMI and the above mentioned changes
after 4 weeks. Extrapolated data from previous studies
allowed calculation of LDL/HDL ratio change between
baseline and after diet or wine intake [25,40,41]. The
extractions from the articles resulted in a 0.03 change in
the no diet group with no wine, 0.1 in the diet group
with no wine and the no diet group with wine, 0.48 in
the diet group with wine. The standard deviation was
extrapolated to 0.02. Assuming an alpha risk of 0.025
(Bonferroni corrected for two comparisons) and a power
of 0.9, the total sample size should be 88 to show a
significant difference between groups by using a general
linear model including the diet and wine groups as well
as their interaction. Allowing for 15% of loss to follow-
up, the sample size should finally be 100 patients.
The intent-to-treat analysis (ITT) included only pa-
tients who had attended the first and at least the 4 weeks
visit. The per-protocol-analysis (PP) included ITT pa-
tients and excluded those who admitted not to haven=122 enrolled in the s
n=60 lifestyle changes
(n=30 no alcohol, n=30 red wine)
n=53 lifestyle changes
(n=25 no alcohol, n=28 red 
wine); follow-up at least until 




After randomization 7 
withdrew consent before 
visit at 4 weeks (gastritis, 
walnut allergy, went on 
holidays, unable to stop 
alcohol consumption, study to 
bothersome, 2 no reason 
given) 
Figure 2 Patient attrition.followed the instructions or who did not present them-
selves at the 20-week visit. The ITT population was the
primary population. The groups (defined by LC and red
wine intake) were compared for their baseline values.
For continuous variables, normality was verified using
the Shapiro-Wilk test. Where normally distributed, a
two-sample t-test was used. Otherwise the Wilcoxon-
Mann–Whitney test was applied. Dichotomous data was
compared using a Pearson’s chi-squared test. In case ex-
pected cell frequencies were lower than 5, Fisher’s exact
test was applied. A general linear model with Tukey-
Kramer adjustment for multiple comparisons was used
to assess the primary endpoints. The change value repre-
sented the dependent value. Lifestyle group (conven-
tional, LC), wine group (with wine, without wine) and
the interaction between lifestyle and wine group were in-
cluded in the model as independent variables as well as
the baseline value as a covariate. In case where the nor-
mality assumption of the model residuals was violated, a
non-parametric van-Elteren test was used with stratifica-
tion for the other intervention (i.e. when comparing LC
vs. no LC, stratification for wine group was used and
vice versa). We looked for an imbalance in statin treat-
ment between the groups by the chi-square test at base-
line, after 4 weeks, and after 20 weeks. A p-value below
0.05 was considered significant. All tests were two-tailed.
All analyses were performed by using the SAS System
v9.2 (SAS Institute, Cary, NC, USA).tudy and randomised
n=62 conventional lifestyle
(n=32 no alcohol, n=30 red wine)
n=55 conventional lifestyle
(n=27 no alcohol, n=28 red 
wine); follow-up at least until 




After randomization 7 
withdrew consent before 
visit at 4 weeks (unable to 
drink wine regularly, 3 unable 
to stop wine consumption, did 
not support 24h BP 
monitoring, convinced that 
red wine is bad for breast 
cancer, no reason given)
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108 patients, 36 women and 72 men aged from 37 to
83 years (mean 64±9 years) were included in the ITT
population (cf. Figure 2).
Among all baseline parameters (demographic, medical
history, lipid profile, nutritional values and physical activity),
no difference was found between groups (cf. Tables 1
and 2). There was homogeneity between the groups
except for the fact that at baseline, subjects in the no-
red-wine group consumed more lipids, proteins and
mono-unsaturated fatty acids and less red wine than
subjects in the red-wine group. No serious adverse
event related to the intervention (LC or wine) was
recorded.Table 1 Baseline demographic values, past medical history, tr
No LC (n = 55) LC (n = 53) p-value
Mean age [years] 63.4 (10.6) 63.7 (8.1) NS
Men [%] 69 64 NS
Mean weight [kg] 81.6 (16.2) 77.2 (16.3) NS
Mean BMI [kg/m2] 27.8 (4.2) 27.3 (4.5) NS
Smoker [%] 11 4 NS
Hypertension [%] 69 66 NS
Hyper-/Dyslipidemia [%] 76 72 NS
Diabetes mellitus [%] 13 11 NS
Previous stroke [%] 20 21 NS
Previous TIA [%] 15 9 NS
Previous MI [%] 11 8 NS
Angina pectoris [%] 7 4 NS
Intermittent claudication [%] 0 2 NS
On statin [%] 65 64 NS
On fibrate [%] 2 4 not tested
On nicotinic acid [%] 0 2 not tested
On ezetrol [%] 9 2 not tested
On fish oil supplements 2 6 not tested
Mean total cholesterol [mg/dL] 178.5 (4.9) 176.2 (5.4) NS
Mean total cholesterol [mmol/L] 4.62 (0.13) 4.56 (0.14) NS
Mean LDL [mg/dL] 105.0 (32.7) 104.8 (32.6) NS*
Mean LDL [mmol/L] 2.72 (0.85) 2.71 (0.84) NS*
Mean HDL [mg/dL] 59.1 (19.6) 57.2 (14.3) NS*
Mean HDL [mmol/L] 1.53 (0.51) 1.48 (0.37) NS*
LDL/HDL 2.0 (0.8) 1.9 (0.7) NS*
Mean triglycerides [mg/dL] 109.1 (77.5) 99.7 (42.0) NS*
Mean triglycerides [mmol/L] 1.23 (0.88) 1.13 (0.47) NS*
Mean Lp(a) [mg/dL] 56.9 (48.8) 56.1 (64.4) NS*
Mean Lp(a) [mmol/L] 2.03 (1.74) 2.00 (2.30) NS*
No differences were found between the LC and the no LC group, as well as betwee
Wilcoxon-Mann–Whitney tests (indicated by *). Categorical values were tested withThe results for the primary endpoint and the secondary
endpoints are presented in Table 3. Four weeks after be-
ginning the intervention, LC and no-LC groups showed
no significant differences in blood lipids. Significant differ-
ences were observable for HDL cholesterol (p = 0.0263)
and LDL/HDL ratio (p = 0.0293). After 20 weeks, LDL was
significantly lowered by 7% in the lifestyle-changes group
compared to the no-lifestyle-changes group (p = 0.0296).
LC lowered the LDL/HDL ratio after 20 weeks by 8%
(p = 0.0242) and red wine independently by 13% (p =
0.0049). Total cholesterol (−6%; p = 0.0238) and triglycer-
ides (−13.2%; p = 0.0361) were lowered significantly by LC
after 20 weeks compared to the no-LC group. Interaction
between LC and wine was not significant in any analysis ofeatment, and lipid profile (SD in brackets)
Red wine (n = 56) No red wine (n = 52) p-value Total
64.1 (9.1) 63.0 (9.9) NS 63.6 (9.5)
68 65 NS 67
79.5 (14.3) 79.4 (18.4) NS 79.4 (16.3)
27.4 (3.9) 27.7 (4.8) NS* 27.6 (4.4)
5 10 NS 7
71 63 NS 68
71 77 NS 74
14 10 NS 12
25 15 NS 20
11 14 NS 12
7 12 NS 9
5 6 NS 6
0 2 NS 1
61 69 NS 66
4 2 not tested 3
2 0 not tested 1
4 8 not tested 6
2 6 not tested 4
178.0 (5.2) 176.8 (5.1) NS 177.4 (37.4)
4.60 (0.13) 4.57 (0.13) NS 4.59 (0.97)
106.5 (33.3) 103.2 (31.8) NS* 104.9 (32.5)
2.75 (0.86) 2.67 (0.82) NS* 2.71 (0.84)
55.9 (15.3) 60.7 (18.8) NS* 58.2 (17.2)
1.45 (0.40) 1.57 (0.49) NS* 1.51 (0.44)
2.0 (0.8) 1.8 (0.8) NS* 1.9 (0.8)
115.7 (78.0) 92.7 (38.1) NS* 104.5 (62.7)
1.31 (0.88) 1.05 (0.43) NS* 1.18 (0.71)
68.2 (67.9) 45.3 (41.8 ) NS* 56.5 (57.0)
2.43 (2.42) 1.62 (1.49) NS* 2.02 (2.03)
n the red wine and the no red wine group in Student’s t tests,
the Chi-square test or Fisher’s exact test.
Table 2 Baseline daily nutritional values and physical activity based on ITT population (mean, SD in brackets)
No LC (n = 55) LC (n = 53) LC effect Red wine (n = 56) No red wine (n = 52) Wine effect Total
Total caloric intake [kJ] 8113 (1928) 8222 (2072) NS 7841 (1946) 8523 (2000) NS 8167 (1992)
Total caloric intake [kcal] 1939 (460.8) 1965 (495.3) NS 1874 (465.1) 2037 (477.9) NS 1952 (476.1)
Carbohydrates [g] 221.8 (62.5) 218.4 (68.8) NS* 214.9 (68.2) 225.8 (62.4) NS* 220.1 (65.4)
Lipids [g] 69.8 (21.9) 72.8 (25.4) NS 66.1 (22.2) 77.0 (24.1) 0.0162 71.3 (23.6)
Proteins [g] 78.8 (17.0) 82.6 (20.5) NS* 77.0 (16.6) 84.8 (20.4) 0.0304 80.7 (18.9)
Vegetables [g] 244.2 (145.3) 248.9 (138.4) NS* 237.5 (116.5) 256.5 (165.0) NS* 246.5 (141.3)
Fruits [g] 237.6 (203.3) 235.9 (208.0) NS* 249.2 (202.2) 223.0 (208.5) NS* 236.7 (204.7)
Fibres [g] 20.2 (8.2) 18.8 (8.2) NS* 20.7 (8.0) 18.1 (8.2) NS* 19.5 (8.2)
Mono-unsaturated fatty acids [g] 21.2 (7.9) 22.7 (8.8) NS* 20.5 (8.2) 23.6 (8.3) 0.0317* 22.0 (8.3)
Poly-unsaturated fatty acids [g] 9.4 (3.5) 10.2 (5.2) NS* 9.2 (3.5) 10.5 (5.2) NS* 9.8 (4.4)
Walnuts [number] 0.5 (1.0) 0.4 (1.5) NS* 0.4 (0.9) 0.4 (1.6) NS* 0.4 (1.2)
Tomatoes [number] 0.4 (0.4) 0.3 (0.5) NS* 0.3 (0.4) 0.4 (0.5) NS* 0.3 (0.5)
Dark chocolate [g] 3.8 (6.9) 3.6 (9.8) NS* 4.5 (10.3) 2.9 (5.8) NS* 3.7 (8.4)
Total alcohol [g] 14.7 (14.7) 14.5 (14.2) NS* 15.4 (14.3) 13.7 (14.6) NS* 14.6 (14.4)
Red wine [mL] 69.8 (98.3) 99.5 (114.7) NS* 102.4 (107.4) 64.8 (104.6) 0.0238* 84.5 (107.2)
White wine [mL] 46.9 (70.6) 26.9 (51.6) NS* 30.7 (59.2) 43.8 (65.8) NS* 37.0 (62.5)
Rosé wine [mL] 9.6 (49.3) 1.9 (13.7) NS* 4.5 (33.4) 7.2 (39.6) NS* 5.8 (36.3)
Beer [mL] 56.6 (133.8) 39.5 (117.9) NS* 36.9 (104.1) 60.4 (146.1) NS* 48.1 (125.8)
Other alcohols [mL] 2.0 (5.9) 2.4 (8.2) NS* 2.8 (7.6) 1.6 (6.5) NS* 2.2 (7.1)
Mild physical activity [min] 282.1 (222.1) 244.6 (180.3) NS* 253.1 (199.8) 275.2 (206.9) NS* 263.7 (202.6)
Moderate physical activity [min] 54.2 (93.4) 44.4 (72.1) NS* 44.0 (62.8) 55.2 (101.4) NS* 49.4 (83.4)
Intensive physical activity [min] 25.7 (60.5) 17.3 (31.3) NS* 20.6 (50.9) 22.7 (46.1) NS* 21.6 (48.4)
P-values are from homogeneity tests (Student’s t-test and Wilcoxon-Mann–Whitney test indicated by *, respectively).
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LC and wine can be considered as independent factors.
Weight and BMI did not change after 20 weeks; there was
only a short effect after 4 weeks in the LC group (0.7%). Lp
(a) was not affected by any intervention. No significant
imbalance was found in statin use throughout the study.
Results obtained on the PP population were similar.
Discussion
Our study demonstrates that in patients with carotid
arteriosclerosis, both, LC and red wine have a beneficial
effect on the LDL/HDL ratio after 20 weeks with an 8%
and 13% decrease, respectively when compared to their
control groups. This effect is already present after
4 weeks in the red-wine intervention group. LDL is sig-
nificantly lowered in the LC group. HDL increased after
4 weeks in the red-wine group. HDL was hardly affected
by LC. The effect of red wine on LDL/HDL was in-
dependent from the lifestyle changes, i.e. there was an
additional benefit. This is a remarkable result as the majority
of our patients (65%) were already on statin treatment
and baseline LDL was already low (104.9 mg/dl). There-
fore both, healthy diet and increased physical activity on
the one hand and a glass of red wine (0.2 l/day for menand 0.1 l/day for women) on the other hand improve
the ratio of LDL and HDL in cerebrovascular patients.
The effect on LDL/HDL ratio after 20 weeks was, how-
ever, more pronounced in the non-LC group. This is
probably due to a ceiling effect. Our study is so far the
largest prospective randomised study using red wine.
Total cholesterol (−6%) and triglycerides (−13%) were
lowered by LC when compared to the non-LC group
after 20 weeks, not after 4 weeks. Lp(a) was not affected
by any intervention.
The beneficial effect of Mediterranean diet on lipids is
well documented. In their recent meta-analysis, Kastorini
et al. found an increase in HDL of 1.17 mg/dl and a de-
crease in triglycerides of 6.14 mg/dl when comparing a
Mediterranean diet with a conventional diet [14]. Some of
the studies included alcohol/red wine, others not. Our
study is so far the first to document an additional effect of
adding red wine to a Mediterranean diet on blood lipids.
Sola et al. investigated the effect of a Mediterranean diet
enriched in mixed nuts in 193 high cardiovascular risk
subjects after 3 months [13]. Compared with baseline,
total cholesterol, LDL, the ratio LDL/HDL, and triglycer-
ides decreased significantly by 3.1%, 4.2%, 4.8%, and 6.2%,
respectively. HDL increased by 1.8%. Regular physical



























Baseline - 4 weeks
Total
cholesterol
0.9 (2.3) −4.2 (1.8) NS −0.6 (2.1) −2.6 (2.1) NS 0.4 (17.0) 1.4 (16.4) −6.0 (12.4) −2.6 (13.9)
LDL 1.5 (20.4) −5.3 (17.6) NS* −2.5 (20.3) −1.1 (18.4) NS* 2.4 (19.3) 0.6 (21.8) −5.1 (16.9) −5.5 (18.5)
HDL 1.1 (2.2) −2.1 (1.5) NS 2.8 (1.8) −3.8 (1.9) 0.0263 −2.8 (16.8) 5.0 (15.0) −5.1 (9.4) 0.6 (11.4)
LDL/HDL 1.7 (20.9) −2.6 (18.7) NS* −4.5 (18.9) 3.9 (20.2) 0.0293* 6.9 (20.9) −3.5 (19.9) 0.6 (19.2) −5.4 (18.2)
Triglycerides 1.1 (29.3) −1.2 (30.3) NS* −2.0 (29.2) 2.1 (30.4) NS* 4.3 (29.6) −2.1 (29.2) −0.4 (31.6) −1.9 (29.7)
Lp (a) 1.6 (21.3) 9.0 (32.7) NS* 5.6 (25.7) 4.9 (29.7) NS* 0.8 (23.9) 2.5 (18.7) 9.4 (35.1) 8.5 (31.1)
Weight/BMI 0.0 (1.4) −0.7 (1.8) 0.0253* −0.1 (1.5) −0.6 (1.8) NS* −0.4 (1.4) 0.4 (1.3) −0.8 (2.1) −0.7 (1.5)
Baseline - 20 weeks
Total cholesterol 3.6 (2.2) −2.4 (2.0) 0.0238 −0.9 (2.0) 2.4 (2.3) NS 7.2 (17.6) 0.5 (13.8) −2.5 (13.0) −2.3 (15.4)
LDL 4.4 (23.3) −3.2 (19.1) 0.0296* −3.3 (20.5) 5.1 (22.1) NS* 11.7 (25.2) −2.0 (20.0) −1.5 (16.4) −4.6 (21.4)
HDL 2.1 (1.9) 2.0 (1.9) NS 4.2 (1.9) −0.3 (1.9) NS −1.5 (12.9) 5.3 (14.4) 0.9 (13.5) 3.0 (13.1)
LDL/HDL 4.3 (28.0) −4.1 (20.6) 0.0242* −6.1 (20.8) 7.3 (27.2) 0.0049* 15.7 (30.8) −5.5 (21.3) −1.1 (20.5) −6.7 (20.7)
Triglycerides 7.0 (35.7) −6.2 (34.7) 0.0361* −3.9 (31.8) 5.5 (39.4) NS* 14.6 (38.3) 0.6 (32.6) −3.5 (39.1) −8.7 (30.9)
Lp (a) 5.0 (28.6) 9.4 (29.6) NS* 6.9 (25.3) 7.9 (33.0) NS* −2.1 (27.3) 11.8 (29.0) 16.9 (35.7) 2.6 (21.3)
Weight/BMI −0.1 (2.4) −0.9 (2.9) NS −0.1 (2.8) −0.8 (2.4) NS −0.8 (2.0) 0.6 (2.6) −0.9 (2.9) −0.9 (2.9)
P-values are from the general linear model. In case of a non-parametric distribution, the van-Elteren test was used (indicated by *). In the upper part changes from
baseline to 4 weeks, in the lower part from baseline to 20 weeks.
Droste et al. Nutrition Journal 2013, 12:147 Page 7 of 9
http://www.nutritionj.com/content/12/1/147exercise also has a beneficial effect on lipids, HDL is in-
creased by about 8%, triglycerides are reduced by about
27% [11]. LDL and total cholesterol are hardly affected.
We included in our diet 3 items known to alter positively
lipid profile and generally accepted in the European
culture: dark chocolate, tomatoes and walnuts, the latter
two being frequently part of a Mediterranean diet [15-20].
Previous studies have investigated the effect of LC and
red wine on cholesterol. Avellone et al. investigated the
effect of 250 ml of red wine daily on cholesterol in 48
subjects over 4 weeks. They found a 10% increase of
HDL (significant) and a trend of a 7% decrease of LDL
(not significant) with the intervention. LDL/HDL im-
proved significantly by 14% [42]. This number of 14% is
comparable to the reduction of LDL/HDL by 13% found
in the present study when comparing the results of the
wine group to the non-alcohol group. In their study, tri-
glycerides decreased by 7%, and Lp(a) by 21%, however
not significantly.
Coimbra et al. investigated 16 healthy adult subjects
with isolated hypercholesterolemia who had to drink
500 ml of red grape juice or 250 ml of red wine daily.
There was no effect on LDL, HDL, triglycerides and Lp
(a) after 2 weeks (compared with baseline) [26]. The dur-
ation of the study may have been too short; however in
another study over 2 weeks, Rifler et al. investigated the
effect of 250 ml of red wine daily in 33 patients post
myocardial infarction [27,43]. Both groups received awestern prudent diet and performed adapted exercise
and physiotherapy. After 2 weeks the wine drinkers had
a 5% decrease in total cholesterol and LDL, respectively,
as compared to baseline, but a 16% and 18% decrease in
total cholesterol and LDL compared to the no-wine
group. Triglycerides did not change. Although the data
of the no-wine group compared to baseline are not
given in the article, this means that the no-wine group
showed an increase in LDL and total cholesterol, a find-
ing also observed in our study. A possible explanation
for this phenomenon is that in our study and in the
study by Rifler et al. (in hospitalised patients) the no-
wine group is as a matter of fact a no-alcohol or stop-
alcohol group. Probably part of these subjects had
consumed alcohol before the study and had to stop
during the study.
In the literature there is conflicting evidence whether
Lp(a) can be affected by lifestyle changes or not, like in
our study. Lp(a) decreased after the regular daily inges-
tion of red wine with 30 g alcohol [44]. In 2 other stud-
ies Lp(a) increased after alcohol withdrawal [45,46]. In a
postmenopausal women, no effect of two alcoholic
drinks a day on Lp(a) was observed [47]. In a Norwegian
study those who exercised increased their Lp(a) levels
with 15.4 (S.E. = 8.0) mg/l as compared to no exercise
(P < 0.05). Also, dietary intervention tended to increase
Lp(a), but the increase did not reach statistical signifi-
cance [48].
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http://www.nutritionj.com/content/12/1/147Our study did not address the intriguing question
whether there is a particularly beneficial effect of red
wine over other forms of alcohol concerning the effect
on blood lipids. Recent reviews suggest that regular
consumption of small quantities of any form of alcohol
prevents cerebro-cardiovascular diseases rather than that
there is a particular benefit of red wine [21,24,49].
Potential limitations of our study are that the study
size was modest, this was an open trial, clinical benefit
was not shown, and the intervention follow-up time was
rather short (20 weeks only). The strength of the study
is the demonstration of an additional beneficial effect of
red wine on top of otherwise healthy lifestyle on blood
lipids.
Conclusions
Lifestyle changes including a modified Mediterranean
diet and physical exercise as well as a glass of red wine
daily improve independently from each other LDL/HDL
ratio in patients with carotid arteriosclerosis even
though the vast majority was already on statin therapy.
This may also translate in a reduction of future heart at-
tacks and strokes. The exact molecules and mechanisms
of the beneficial effect of red wine on blood lipids can be
deciphered in future studies.
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